The European Medicines Agency (EMA) has started an urgent review of the multiple sclerosis medicine Zinbryta (daclizumab) following 7 cases of serious inflammatory brain disorders in Germany, including encephalitis and meningoencephalitis, and one case in Spain.
The National Pharmaceutical Pricing Authority fixes/revises the price of the Scheduled formulation.
The scheduled formulations are: Atorvastatin + Aspirin Capsule (Atchol-ASP 150), Nifedipine + Lidocaine Cream (LOXHEAL), Pioglitazone + Gliclazide + Metformin Tablet (GLZ Total), Ibuprofen + Paracetamol Tablet (Brufen Plus), Misoprostol Tablet, Glimepiride + Metformin Tablet, Melphalan + Povidone Injection (Melphalan Injection IP 50mg), Trastuzumab Injection, Vitamin D3
(Cholecalciferol) (DRISE SURE), Furosemide Injection, Snake Venom Antiserum-Soluble/ Liquid Polyvalent Injection, and Phenobarbitone oral liquid.
The U.S. Food and Drug Administration is alerting health care professionals and patients not to use drug products produced by Cantrell Drug Company of Little Rock, Arkansas, including opioid products and other drugs intended for sterile injection, that were produced by the company and distributed nationwide.
U.S. Food and Drug Administration’s ongoing efforts to protect consumers from health fraud. The FDA is warning consumers to be alert, and try and steer clear of fraudulent flu products, which may be found online or in retail stores. The agency protecting consumers of unapproved products claiming to prevent, treat or cure influenza, or flu.
Zosano Pharma Corp a clinical stage biopharmaceutical company focused on providing rapid systemic administration of therapeutics to subjects using its proprietary Adhesive Dermally-Applied Microarray (“ADAM™”) technology, today announced that the previously announced Notice of Allowance of our patent application titled “Method of Rapidly Achieving Therapeutic Concentrations of Triptans for Treatment of Migraines” has resulted in the issuance of a U.S. patent 9,918,932. The inventors were Dr. Mahmoud Ameri, Dr. Don Kellerman, Dr. Yi Ao, and Dr. Peter Dadonna, all of whom are current or former employees of Zosano.
CLICK HERE TO SUBSCRIBE,
PHARMATUTOR's DAILY EMAILS
Do Not Forget to Verify
(Click on Subscription link in your inbox)
--------
Novartis has one of the most exciting product pipelines in the industry today. A pipeline of innovative medicines brought to life by diverse, talented and performance driven people. All of which makes them one of the most rewarding employers in their field.
DXC Technology helps clients harness the power of innovation to thrive on change. For more than 60 years, we have successfully guided the world’s largest enterprises and government agencies through successful change cycles. We take pride in our technology independence and our role as a trusted advisor. Our deep experience gives us a clear and confident vision to help clients navigate the future. As the world’s leading independent, end-to- end IT services company, we are uniquely positioned to lead digital transformations — creating greater value for clients, partners and shareholders, and presenting growth opportunities for our people. We are among the world’s best corporate citizens.
Baxter provides a broad portfolio of essential renal and hospital products, including home, acute and in-centre dialysis; sterile IV solutions; infusion systems and devices; parenteral nutrition; surgery products and anesthetics; and pharmacy automation, software and services. The company’s global footprint and the critical nature of its products and services play a key role in expanding access to healthcare in emerging and developed countries. Baxter’s employees worldwide are building upon the company’s rich heritage of medical breakthroughs to advance the next generation of healthcare innovations that enable patient care.
